Research Studies » PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)

PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)
MULTI-CENTER, MULTIPLE-DOSE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SILDENAFIL CREAM, 3.6% IN PREMENOPAUSAL PATIENTS WITH FEMALE SEXUAL AROUSAL DISORDER (FSAD)
Powered By RealTime-CTMS Clinical Trial Management System